Phase 4 Membranous Nephropathy Clinical Trials

5 recruitingPhase 4

What is a Phase 4 trial?

Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.

Showing 1–5 of 5 trials

Recruiting

Phase 4

Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy

Primary Membranous Nephropathy

First Affiliated Hospital, Sun Yat-Sen University116 enrolled1 locationNCT06573411

Recruiting

Phase 4

Rivaroxaban in Idiopathic Membranous Nephropathy

Idiopathic Membranous Nephropathy

Beijing Friendship Hospital134 enrolled1 locationNCT07404436

Recruiting

Phase 4

Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy

NephropathyGlomerular DiseasesIdiopathic Membranous Nephropathy

Chinese PLA General Hospital480 enrolled1 locationNCT05839314

Recruiting

Phase 4

Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy

Primary Membranous Nephropathy

First Affiliated Hospital, Sun Yat-Sen University78 enrolled1 locationNCT05514015

Completed

Phase 4

Randomized prospective trial of cyclosporine with/without low-dose prednisolone in idiopathic membranous nephropathy in adults with nephrotic syndrome

idiopathic membranous nephropathy with nephrotic syndrome

Research Group for Treatments of Kidney Diseases in Ibaraki, Japan30 enrolled1 locationACTRN12609000996268